Gateneuro
Carmel, US · Founded 2018 · 1 known investors
Syndeio Biosciences (Gate Neurosciences) is a synapse-focused biotech developing drug candidates for neuropsychiatric, mental health, and cognitive disorders such as depression, Alzheimer's, and schizophrenia. Its pipeline includes NMDA-receptor positive allosteric modulators like zelquistinel and apimostinel, supported by a proprietary synapse pharmacology platform originating from a Stanford University laboratory.
Founders & leadership
Gateneuro was founded in 2018 by Derek Small.
DS
Derek SmallFounder
MM
Michael McCullyExecutive
Investors · 1
Reported raises · per SEC filings
Form D private placements$16.1M disclosed across 2 rounds · 2020–2021
▶$15MraisedDec 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedDec 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael McCullyExecutive Officer, Director
- Derek SmallExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.1MraisedAug 2020 · 4 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedAug 2020 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael McCullyExecutive Officer
- Derek SmallExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.1M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Gateneuro do?
- Syndeio Biosciences (Gate Neurosciences) is a synapse-focused biotech developing drug candidates for neuropsychiatric, mental health, and cognitive disorders such as depression, Alzheimer's, and schizophrenia. Its pipeline includes NMDA-receptor positive allosteric modulators like zelquistinel and apimostinel, supported by a proprietary synapse pharmacology platform originating from a Stanford University laboratory.
- Who founded Gateneuro?
- Gateneuro was founded by Derek Small in 2018.
- Who are Gateneuro's investors?
- Gateneuro's investors include Evolution VC Partners.
- How much funding has Gateneuro raised?
- Gateneuro has disclosed $16.1M raised across 2 rounds.
- Where is Gateneuro headquartered?
- Gateneuro is headquartered in Carmel, US.